The University of Massachusetts Amherst (the University) has an Institutional Biosafety Committee (IBC) in compliance with the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines, 2002) and in accordance with Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition, 2007.
The Institutional Biosafety Committee (IBC) is a University-wide review body that provides oversight over University operations and activities of a potentially biologically hazardous nature. The IBC reviews and approves research that involves potentially biohazardous materials (plant and animal pathogens, oncogenes, carcinogens, toxins and recombinant DNA), as required by University, State and Federal directives. The IBC currently has eleven members and meets at least four times a year. Questions as to whether a material is a potential biohazard should be directed to the Biological Safety Officer in Environmental Health and Safety (EHS) at 545-2682.
The IBC follows NIH Guidelines for practices for reviewing projects that require constructing and handling: (i) rDNA molecules, and (ii) organisms and viruses containing rDNA molecules. The IBC also reviews activities involving use of Select Agents and Toxins and other biohazardous agents that must be handled at BSL3 and 4. The IBC assists the EHS Biosafety Officer in formulating policies and procedures related to the use of biohazards. The IBC is also charged with reviewing the biological and medical waste management program annually and may advise the institution and the Principal Investigator (PI) concerning management of research that is classified as “dual use”.
- Biohazardous Materials in Research and Instruction Policy
- Recombinant DNA or synthetic DNA research
- Select Agents
- Dual Use Research
IBC Meeting Schedule:
Please contact Barbara Miller at 545-0668 or firstname.lastname@example.org for the current IBC Meeting Schedule.
Biosafety Training is handled by Environmental Health and Safety.